JSW
AMGN icon

Journey Strategic Wealth’s Amgen AMGN Stock Holding History

Journey Strategic Wealth’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.08M Buy
5,915
+743
+14% +$265K 0.05% 101
2025
Q4 		$1.69M Buy
5,172
+137
+3% +$43.5K 0.04% 112
2025
Q3 		$1.42M Sell
5,035
-366
-7% -$106K 0.04% 127
2025
Q2 		$1.51M Buy
5,401
+2,601
+93% +$737K 0.05% 117
2025
Q1 		$872K Sell
2,800
-211
-7% -$62.3K 0.03% 145
2024
Q4 		$785K Sell
3,011
-3
-0.1% -$890 0.03% 153
2024
Q3 		$971K Buy
3,014
+897
+42% +$293K 0.04% 131
2024
Q2 		$662K Buy
2,117
+1,137
+116% +$334K 0.03% 132
2024
Q1 		$279K Buy
+980
New +$287K 0.01% 204
2023
Q2 		– Sell
-1,126
Closed -$272K – 207
2023
Q1 		$272K Sell
1,126
-217
-16% -$53.3K 0.03% 173
2022
Q4 		$353K Buy
1,343
+323
+32% +$86.6K 0.04% 130
2022
Q3 		$230K Buy
+1,020
New +$247K 0.03% 134

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Journey Strategic Wealth's AMGN Position: Q1 2026 in Review

Journey Strategic Wealth increased its Amgen (AMGN) stake by 14% in Q1 2026, buying an estimated $265K and bringing the position to 5,915 shares worth $2.08M. The position accounts for 0.05% of the portfolio, ranked #101.

Journey Strategic Wealth first reported a position in AMGN in Q3 2022 and has held it in 12 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Journey Strategic Wealth held 5,915 shares of Amgen worth $2.08M as of Q1 2026.
  • Journey Strategic Wealth bought 743 Amgen shares in Q1 2026, an estimated $265K.
  • Amgen made up 0.05% of Journey Strategic Wealth's portfolio in Q1 2026, its #101 holding.
  • Journey Strategic Wealth first reported a position in Amgen in Q3 2022 and has held it in 12 quarters since.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Journey Strategic Wealth's 13F filing for Q1 2026, filed 15 Apr 2026.